Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN

Journal of General Virology

Volumn 90, Issue 7, 2009, Pages 1600-1610

  Adams, William C ^a,b,c   Bond, Emily ^a,b   Havenga, Menzo J E ^d   Holterman, Lennart ^e   Goudsmit, Jaap ^e   Hedestam, Gunilla B Karlsson ^a,b   Koup, Richard A ^c   Loré, Karin ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d TNO   (Netherlands)

^e CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECTIN 1; LACTOFERRIN; ADENOVIRUS RECEPTOR; CARRIER PROTEIN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CXADR PROTEIN, HUMAN; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LACTOFERRIN PROTEIN, HUMAN; LECTIN; VIRUS RECEPTOR;

ADENOVIRUS 5; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LANGERHANS CELL; MONOCYTE; NONHUMAN; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CELL; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; CELL CULTURE; HUMAN ADENOVIRUS; PHYSIOLOGY; VIROLOGY;

ADENOVIRIDAE; COXSACKIEVIRUS;

ADENOVIRUSES, HUMAN; CARRIER PROTEINS; CELL ADHESION MOLECULES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; LECTINS, C-TYPE; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; VIRUS ATTACHMENT;

EID: 67849101445     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.008342-0     Document Type: Article

References (60)

1. Barouch, D. H. & Nabel, G. J. (2005). Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther 16, 149-156.
2. Barouch, D. H., Pau, M. G., Custers, J. H., Koudstaal, W., Kostense, S., Havenga, M. J., Truitt, D. M., Sumida, S. M., Kishko, M. G. & other authors (2004). Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol 172, 6290-6297.
3. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L. & Finberg, R. W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
4. Cheng, C., Gall, J.G., Kong, W. P., Sheets, R. L., Gomez, P. L., King, C. R. & Nabel, G. J. (2007). Mechanism of Ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog 3, e25.
5. Coddeville, B., Strecker, G., Wieruszeski, J. M., Vliegenthart, J. F., van Halbeek, H., Peter-Katalinic, J., Egge, H. & Spik, G. (1992). Heterogeneity of bovine lactotransferrin glycans. Characterization of α-D-Galp-(1→3)-β-D-Gal- and α-NeuAc-(2→6)-β-D-GalpNAc- (1→4)-β-D-GlcNAc-substituted N-linked glycans. Carbohydr Res 236, 145-164.
6. Cohen, C. J., Shieh, J. T., Pickles, R. J., Okegawa, T., Hsieh, J. T. & Bergelson, J. M. (2001). The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 98, 15191-15196.
7. Dechecchi, M. C., Tamanini, A., Bonizzato, A. & Cabrini, G. (2000). Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268, 382-390.
8. Dechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M. & Cabrini, G. (2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 75, 8772-8780.
9. de Gruijl, T. D., Ophorst, O. J., Goudsmit, J., Verhaagh, S., Lougheed, S. M., Radosevic, K., Havenga, M. J. & Scheper, R. J. (2006). Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells. J Immunol 177, 2208-2215.
10. de la Rosa, G., Yang, D., Tewary, P., Varadhachary, A. & Oppenheim, J. J. (2008). Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol 180, 6868-6876.
11. Di Biase, A. M., Pietrantoni, A., Tinari, A., Siciliano, R., Valenti, P., Antonini, G., Seganti, L. & Superti, F. (2003). Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J Med Virol 69, 495-502.
12. Drobni, P., Naslund, J. & Evander, M. (2004). Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res 64, 63-68.
13. Ebbinghaus, C., Al-Jaibaji, A., Operschall, E., Schoffel, A., Peter, I., Greber, U. F. & Hemmi, S. (2001). Functional and selective targeting of adenovirus to high-affinity Fcγ receptor I-positive cells by using a bispecific hybrid adapter. J Virol 75, 480-489.
14. Groot, F., Geijtenbeek, T. B., Sanders, R. W., Baldwin, C. E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E. C. & Berkhout, B. (2005). Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J Virol 79, 3009-3015.
15. Havenga, M. J., Lemckert, A. A., Grimbergen, J. M., Vogels, R., Huisman, L. G., Valerio, D., Bout, A. & Quax, P. H. (2001). Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75, 3335-3342.
16. Hidaka, C., Milano, E., Leopold, P. L., Bergelson, J. M., Hackett, N. R., Finberg, R. W., Wickham, T. J., Kovesdi, I., Roelvink, P. & Crystal, R. G. (1999). CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 103, 579-587.
17. Hsu, K. H., Lonberg-Holm, K., Alstein, B. & Crowell, R. L. (1988). A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 62, 1647-1652.
18. Johansson, C., Jonsson, M., Marttila, M., Persson, D., Fan, X. L., Skog, J., Frangsmyr, L., Wadell, G. & Arnberg, N. (2007). Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J Virol 81, 954-963.
19. Korokhov, N., de Gruijl, T. D., Aldrich, W. A., Triozzi, P. L., Banerjee, P. T., Gillies, S. D., Curiel, T. J., Douglas, J. T., Scheper, R. J. & Curiel, D. T. (2005). High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN. Cancer Biol Ther 4, 289-294.
20. Legrand, D., Elass, E., Carpentier, M. & Mazurier, J. (2005). Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62, 2549-2559.
21. Leopold, P. L., Wendland, R. L., Vincent, T. & Crystal, R. G. (2006). Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway. J Virol 80, 10237-10247.
22. Li, E., Stupack, D., Klemke, R., Cheresh, D. A. & Nemerow, G. R. (1998). Adenovirus endocytosis via av integrins requires phosphoinositide-3-OH kinase. J Virol 72, 2055-2061.
23. Lore, K., Sonnerborg, A., Spetz, A. L., Andersson, U. & Andersson, J. (1998). Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. J Immunol Methods 214, 97-111.
24. Lore, K., Betts, M. R., Brenchley, J. M., Kuruppu, J., Khojasteh, S., Perfetto, S., Roederer, M., Seder, R. A. & Koup, R. A. (2003). Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus-and HIV-1-specific T cell responses. J Immunol 171, 4320- 4328.
25. + T cells. J Exp Med 201, 2023- 2033.
26. Lore, K., Adams, W. C., Havenga, M., Precopio, M. L., Holterman, L., Goudsmit, J. & Koup, R. A. (2007). Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses. J Immunol 179, 1721-1729.
27. 3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens. Vaccine 24, 671-682.
28. Masson, P. L., Heremans, J. F. & Dive, C. H. (1966). An iron-binding protein common to many external secretions. Clin Chim Acta 14, 735-739.
29. McConnell, M. J. & Imperiale, M. J. (2004). Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther 15, 1022-1033.
30. Miyazawa, K., Mantel, C., Lu, L., Morrison, D. C. & Broxmeyer, H. E. (1991). Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J Immunol 146, 723-729.
31. + T lymphocytes. J Clin Invest 115, 3256-3264.
32. Pierce, A., Colavizza, D., Benaissa, M., Maes, P., Tartar, A., Montreuil, J. & Spik, G. (1991). Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem 196, 177-184.
33. Pietrantoni, A., Di Biase, A. M., Tinari, A., Marchetti, M., Valenti, P., Seganti, L. & Superti, F. (2003). Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother 47, 2688-2691.
34. Puddu, P., Valenti, P. & Gessani, S. (2009). Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 91, 11-18.
35. Rea, D., Havenga, M. J., van Den Assem, M., Sutmuller, R. P., Lemckert, A., Hoeben, R. C., Bout, A., Melief, C. J. & Offringa, R. (2001). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166, 5236-5244.
36. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J. P. & Ricciardi-Castagnoli, P. (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361-367.
37. Roelvink, P. W., Kovesdi, I. & Wickham, T. J. (1996). Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J Virol 70, 7614-7621.
38. Roelvink, P. W., Lizonova, A., Lee, J. G., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I. & Wickham, T. J. (1998). The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 72, 7909-7915.
39. Rozis, G., de Silva, S., Benlahrech, A., Papagatsias, T., Harris, J., Gotch, F., Dickson, G. & Patterson, S. (2005). Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines. Eur J Immunol 35, 2617-2626.
40. Smed-Sorensen, A., Lore, K., Vasudevan, J., Louder, M. K., Andersson, J., Mascola, J. R., Spetz, A. L. & Koup, R. A. (2005). Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79, 8861-8869.
41. Smith, T. A., Idamakanti, N., Marshall-Neff, J., Rollence, M. L., Wright, P., Kaloss, M., King, L., Mech, C., Dinges, L. & other authors (2003). Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum Gene Ther 14, 1595-1604.
42. Spadaro, M., Caorsi, C., Ceruti, P., Varadhachary, A., Forni, G., Pericle, F. & Giovarelli, M. (2008). Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J 22, 2747-2757.
43. Spik, G., Coddeville, B. & Montreuil, J. (1988). Comparative study of the primary structures of sero-, lacto- and ovotransferrin glycans from different species. Biochimie 70, 1459-1469.
44. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176, 2161-2172.
45. Suzuki, Y. A. & Lonnerdal, B. (2002). Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol 80, 75-80.
46. Suzuki, Y. A., Lopez, V. & Lonnerdal, B. (2005). Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 62, 2560-2575.
47. Tatsis, N. & Ertl, H. C. (2004). Adenoviruses as vaccine vectors. Mol Ther 10, 616-629.
48. Tillman, B. W., de Gruijl, T. D., Luykx-de Bakker, S. A., Scheper, R. J., Pinedo, H. M., Curiel, T. J., Gerritsen, W. R. & Curiel, D. T. (1999). Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol 162, 6378-6383.
49. Tomko, R. P., Xu, R. & Philipson, L. (1997). HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94, 3352-3356.
50. Turville, S. G., Cameron, P. U., Handley, A., Lin, G., Pohlmann, S., Doms, R. W. & Cunningham, A. L. (2002). Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3, 975-983.
51. van Berkel, P. H., van Veen, H. A., Geerts, M. E., de Boer, H. A. & Nuijens, J. H. (1996). Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem J 319, 117-122.
52. van der Strate, B. W., Beljaars, L., Molema, G., Harmsen, M. C. & Meijer, D. K. (2001). Antiviral activities of lactoferrin. Antiviral Res 52, 225-239.
53. Waarts, B. L., Aneke, O. J., Smit, J. M., Kimata, K., Bittman, R., Meijer, D. K. & Wilschut, J. (2005). Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate. Virology 333, 284-292.
54. Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M., Greig, J. A. & other authors (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132, 397-409.
55. Wally, J. & Buchanan, S. K. (2007). A structural comparison of human serum transferrin and human lactoferrin. Biometals 20, 249-262.
56. Wang, K., Huang, S., Kapoor-Munshi, A. & Nemerow, G. (1998). Adenovirus internalization and infection require dynamin. J Virol 72, 3455-3458.
57. Weinberg, E. D. (2001). Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 53, 1303-1310.
58. 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
59. Wu, L., Martin, T. D., Vazeux, R., Unutmaz, D. & KewalRamani, V. N. (2002). Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J Virol 76, 5905-5914.
60. Xie, J., Chiang, L., Contreras, J., Wu, K., Garner, J. A., Medina-Kauwe, L. & Hamm-Alvarez, S. F. (2006). Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol 80, 11833-11851.